American house dust mite allergenic extract 30000 AU/ML Injectable Solution — RxCUI 854052
RxNorm drug concept · Semantic clinical drug
RxCUI 854052
Semantic clinical drug · SCD
● Current RxNorm concept 7 FDA products
17 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI854052
Official nameAmerican house dust mite allergenic extract 30000 AU/ML Injectable Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asDermatophagoides farinae extract 30,000 AU/ML Injectable Solution; American house dust mite extract 30000 AU/ML Injectable Solution
FDA products mapped7
Package NDCs mapped17
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
🕸️ Concept Web — How American house dust mite allergenic extract 3000... Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
American house dust mite allergenic extract 30000 AU/ML Injectable Solution
RxCUI 854052 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
American house dust mite allergenic extract
1116977IN
-
American house dust mite allergenic extract
-
Dose forms 4
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
American house dust mite allergenic extract Injectable Solution
1926213SCDF -
American house dust mite allergenic extract Injectable Product
1926212SCDG -
Injectable Solution
316949DF -
Injectable Product
1151126DFG
-
American house dust mite allergenic extract Injectable Solution
-
Clinical & branded drugs 1
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
American house dust mite allergenic extract 30000 AU/ML
1926229SCDC
-
American house dust mite allergenic extract 30000 AU/ML
Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
American house dust mite allergenic extract 30000 AU/ML
SCDC · 1926229 -
American house dust mite allergenic extract Injectable Solution
SCDF · 1926213 -
American house dust mite allergenic extract Injectable Product
SCDG · 1926212
📦 FDA Products & Package NDCs
7 products · 17 package NDCs
17 package NDCs map to RxCUI 854052 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 22840-0033-06 | 10 mL in 1 VIAL, MULTI-DOSE (22840-0033-6) | Standardized Mite Dermatophagoides farinae | Greer Laboratories, Inc. | 1987-02-02 |
| 22840-0033-09 | 50 mL in 1 VIAL, MULTI-DOSE (22840-0033-9) | Standardized Mite Dermatophagoides farinae | Greer Laboratories, Inc. | 1987-02-02 |
| 22840-0034-03 | 5 mL in 1 BOTTLE, DROPPER (22840-0034-3) | Standardized Mite Dermatophagoides farinae | Greer Laboratories, Inc. | 1987-02-02 |
| 22840-0034-06 | 10 mL in 1 VIAL, MULTI-DOSE (22840-0034-6) | Standardized Mite Dermatophagoides farinae | Greer Laboratories, Inc. | 1987-02-02 |
| 22840-0034-09 | 50 mL in 1 VIAL, MULTI-DOSE (22840-0034-9) | Standardized Mite Dermatophagoides farinae | Greer Laboratories, Inc. | 1987-02-02 |
| 22840-0035-06 | 10 mL in 1 VIAL, MULTI-DOSE (22840-0035-6) | Standardized Mite Dermatophagoides pteronyssinus | Greer Laboratories, Inc. | 1989-06-27 |
| 22840-0035-09 | 50 mL in 1 VIAL, MULTI-DOSE (22840-0035-9) | Standardized Mite Dermatophagoides pteronyssinus | Greer Laboratories, Inc. | 1989-06-27 |
| 22840-0036-03 | 5 mL in 1 BOTTLE, DROPPER (22840-0036-3) | Standardized Mite Dermatophagoides pteronyssinus | Greer Laboratories, Inc. | 1989-06-27 |
| 22840-0036-06 | 10 mL in 1 VIAL, MULTI-DOSE (22840-0036-6) | Standardized Mite Dermatophagoides pteronyssinus | Greer Laboratories, Inc. | 1989-06-27 |
| 22840-0036-09 | 50 mL in 1 VIAL, MULTI-DOSE (22840-0036-9) | Standardized Mite Dermatophagoides pteronyssinus | Greer Laboratories, Inc. | 1989-06-27 |
| 22840-0037-03 | 5 mL in 1 BOTTLE, DROPPER (22840-0037-3) | Standardized Mite Mix Dermatophagoides farinae and Dermatophagoides pteronyssinus | Greer Laboratories, Inc. | 2010-02-03 |
| 22840-0037-06 | 10 mL in 1 VIAL, MULTI-DOSE (22840-0037-6) | Standardized Mite Mix Dermatophagoides farinae and Dermatophagoides pteronyssinus | Greer Laboratories, Inc. | 2010-02-03 |
| 22840-0037-09 | 50 mL in 1 VIAL, MULTI-DOSE (22840-0037-9) | Standardized Mite Mix Dermatophagoides farinae and Dermatophagoides pteronyssinus | Greer Laboratories, Inc. | 2010-02-03 |
| 22840-0038-06 | 10 mL in 1 VIAL, MULTI-DOSE (22840-0038-6) | Standardized Mite Dermatophagoides farinae | Greer Laboratories, Inc. | 2010-02-03 |
| 22840-0038-09 | 50 mL in 1 VIAL, MULTI-DOSE (22840-0038-9) | Standardized Mite Dermatophagoides farinae | Greer Laboratories, Inc. | 2010-02-03 |
| 22840-0039-06 | 10 mL in 1 VIAL, MULTI-DOSE (22840-0039-6) | Standardized Mite Dermatophagoides pteronyssinus | Greer Laboratories, Inc. | 2010-02-03 |
| 22840-0039-09 | 50 mL in 1 VIAL, MULTI-DOSE (22840-0039-9) | Standardized Mite Dermatophagoides pteronyssinus | Greer Laboratories, Inc. | 2010-02-03 |
Observed labelers:
Greer Laboratories, Inc. (17)
— this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.